4527.T
ROHTO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 3,057.00
+0.59%Aug 7, 2026, 03:39 UTC
Rohto Pharmaceutical announced its first-quarter results, with operating profit of 13.7 billion yen, up 16.8% year-on-year, exceeding market expectations of about 12 billion yen.
Source:Aug 6, 2026, 08:30 UTC
Wellnex Life Limited entered into a binding agreement to sell its Pain Away business and assets to Mentholatum Australasia Pty Ltd for up to A$21.3 million, subject to shareholder approval.
Jul 9, 2026, 10:07 UTC
Rohto Pharmaceutical acquired a majority stake in Magic Cod, a Serbian cosmetics sales agency, on July 8, 2026, to strengthen its European operations.
Source:Jun 29, 2026, 12:15 UTC
Rohto Pharmaceutical and T2 began a Level 2 autonomous truck trial on the Kansai-Kanto corridor in Japan on June 29.
Source: